These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19899394)

  • 21. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J; Van Damme P; Beutels P
    Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of quality assurance/quality control.
    Johnson DW
    Dev Biol Stand; 1992; 79():193-200. PubMed ID: 1286758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and gains associated with vaccination.
    Perkins FT
    Dev Biol Stand; 1980; 46():3-13. PubMed ID: 7364153
    [No Abstract]   [Full Text] [Related]  

  • 26. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
    Levin A; Levin C; Kristensen D; Matthias D
    Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of new vaccines in immunization programs.
    Koplan JP
    Isr J Med Sci; 1986; 22(3-4):272-6. PubMed ID: 2943694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
    Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
    Weycker D; Richardson E; Oster G
    Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-effectiveness of influenza vaccination The Netherlands].
    Reinders A; Postma MJ; Govaert TM; Sprenger MJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-benefit analysis of vaccination against paratuberculosis in dairy cattle.
    van Schaik G; Kalis CH; Benedictus G; Dijkhuizen AA; Huirne RB
    Vet Rec; 1996 Dec 21-28; 139(25):624-7. PubMed ID: 9123788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cost-effectiveness of pneumococcal vaccination in Catalonia].
    Plans Rubió P; Garrido Morales P; Salleras Sanmartí L
    Rev Esp Salud Publica; 1995; 69(5):409-17. PubMed ID: 8564860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Time to change child vaccination programs. Swedish children can get better protection--but it costs more].
    Norrby R
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2376-8. PubMed ID: 16184886
    [No Abstract]   [Full Text] [Related]  

  • 35. Technical network for logistics in health (Technet).
    Wkly Epidemiol Rec; 1999 Apr; 74(17):129-35. PubMed ID: 10382370
    [No Abstract]   [Full Text] [Related]  

  • 36. The cost-effectiveness of vaccinating against Lyme disease.
    Prybylski D
    Emerg Infect Dis; 1999; 5(5):727-8. PubMed ID: 10511535
    [No Abstract]   [Full Text] [Related]  

  • 37. [The new STIKO-SOP: ethical considerations].
    Rothenberger LG
    Gesundheitswesen; 2014 Oct; 76(10):621-2. PubMed ID: 24046160
    [No Abstract]   [Full Text] [Related]  

  • 38. Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology.
    Thomas LF; Bellet C; Rushton J
    Vaccine; 2019 Jul; 37(30):3974-3980. PubMed ID: 30340883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Financing children's vaccines.
    Nelson EA; Sack D; Wolfson L; Walker DG; Seng LF; Steele D
    Vaccine; 2009 Nov; 27 Suppl 5():F12-7. PubMed ID: 19931710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valuing vaccines: deficiencies and remedies.
    Bloom DE
    Vaccine; 2015 Jun; 33 Suppl 2():B29-33. PubMed ID: 26022563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.